DNLI
Price
$27.66
Change
+$0.45 (+1.65%)
Updated
Nov 5, 04:00 PM (EDT)
118 days until earnings call
NKTR
Price
$1.39
Change
+$0.06 (+4.51%)
Updated
Nov 5, 04:00 PM (EDT)
2 days until earnings call
Ad is loading...

DNLI vs NKTR

Header iconDNLI vs NKTR Comparison
Open Charts DNLI vs NKTRBanner chart's image
Denali Therapeutics
Price$27.66
Change+$0.45 (+1.65%)
Volume$57.71K
CapitalizationN/A
Nektar Therapeutics
Price$1.39
Change+$0.06 (+4.51%)
Volume$300.64K
CapitalizationN/A
View a ticker or compare two or three
DNLI vs NKTR Comparison Chart
Loading...
DNLI
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
NKTR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
DNLI vs. NKTR commentary
Nov 06, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DNLI is a Buy and NKTR is a StrongBuy.

COMPARISON
Comparison
Nov 06, 2024
Stock price -- (DNLI: $27.21 vs. NKTR: $1.34)
Brand notoriety: DNLI: Not notable vs. NKTR: Notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DNLI: 71% vs. NKTR: 479%
Market capitalization -- DNLI: $3.96B vs. NKTR: $257.71M
DNLI [@Biotechnology] is valued at $3.96B. NKTR’s [@Biotechnology] market capitalization is $257.71M. The market cap for tickers in the [@Biotechnology] industry ranges from $488.28B to $0. The average market capitalization across the [@Biotechnology] industry is $2.82B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DNLI’s FA Score shows that 0 FA rating(s) are green whileNKTR’s FA Score has 0 green FA rating(s).

  • DNLI’s FA Score: 0 green, 5 red.
  • NKTR’s FA Score: 0 green, 5 red.
According to our system of comparison, NKTR is a better buy in the long-term than DNLI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DNLI’s TA Score shows that 4 TA indicator(s) are bullish while NKTR’s TA Score has 6 bullish TA indicator(s).

  • DNLI’s TA Score: 4 bullish, 5 bearish.
  • NKTR’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, NKTR is a better buy in the short-term than DNLI.

Price Growth

DNLI (@Biotechnology) experienced а -2.05% price change this week, while NKTR (@Biotechnology) price change was -1.47% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.79%. For the same industry, the average monthly price growth was +15.00%, and the average quarterly price growth was +10.61%.

Reported Earning Dates

DNLI is expected to report earnings on Mar 03, 2025.

NKTR is expected to report earnings on Feb 27, 2025.

Industries' Descriptions

@Biotechnology (+4.79% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DNLI($3.9B) has a higher market cap than NKTR($247M). NKTR YTD gains are higher at: 137.168 vs. DNLI (26.794). NKTR has higher annual earnings (EBITDA): -146.03M vs. DNLI (-486.71M). DNLI has more cash in the bank: 896M vs. NKTR (271M). DNLI has less debt than NKTR: DNLI (48.8M) vs NKTR (112M). NKTR has higher revenues than DNLI: NKTR (93.2M) vs DNLI (1.27M).
DNLINKTRDNLI / NKTR
Capitalization3.9B247M1,577%
EBITDA-486.71M-146.03M333%
Gain YTD26.794137.16820%
P/E RatioN/AN/A-
Revenue1.27M93.2M1%
Total Cash896M271M331%
Total Debt48.8M112M44%
FUNDAMENTALS RATINGS
DNLI vs NKTR: Fundamental Ratings
DNLI
NKTR
OUTLOOK RATING
1..100
6072
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
58
Fair valued
PROFIT vs RISK RATING
1..100
80100
SMR RATING
1..100
9398
PRICE GROWTH RATING
1..100
4344
P/E GROWTH RATING
1..100
9987
SEASONALITY SCORE
1..100
7531

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NKTR's Valuation (58) in the Biotechnology industry is somewhat better than the same rating for DNLI (93). This means that NKTR’s stock grew somewhat faster than DNLI’s over the last 12 months.

DNLI's Profit vs Risk Rating (80) in the Biotechnology industry is in the same range as NKTR (100). This means that DNLI’s stock grew similarly to NKTR’s over the last 12 months.

DNLI's SMR Rating (93) in the Biotechnology industry is in the same range as NKTR (98). This means that DNLI’s stock grew similarly to NKTR’s over the last 12 months.

DNLI's Price Growth Rating (43) in the Biotechnology industry is in the same range as NKTR (44). This means that DNLI’s stock grew similarly to NKTR’s over the last 12 months.

NKTR's P/E Growth Rating (87) in the Biotechnology industry is in the same range as DNLI (99). This means that NKTR’s stock grew similarly to DNLI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DNLINKTR
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
70%
Momentum
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
86%
MACD
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
75%
Advances
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
76%
Declines
ODDS (%)
Bearish Trend 6 days ago
78%
Bearish Trend 6 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
73%
Aroon
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
69%
View a ticker or compare two or three
Ad is loading...
DNLI
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
NKTR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IMCGX9.930.02
+0.20%
Transamerica Mid Cap Growth I
ASVHX11.100.02
+0.18%
American Century Small Cap Value G
FMUIX14.710.01
+0.07%
Federated Hermes Muni and Stock Adv IS
DTCCX15.32-0.09
-0.58%
BNY Mellon Sust US Equity C
RYTSX50.82-0.38
-0.74%
Rydex Transportation A

DNLI and

Correlation & Price change

A.I.dvisor indicates that over the last year, DNLI has been loosely correlated with BEAM. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if DNLI jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DNLI
1D Price
Change %
DNLI100%
+0.59%
BEAM - DNLI
65%
Loosely correlated
+6.24%
NTLA - DNLI
58%
Loosely correlated
+2.30%
ALEC - DNLI
58%
Loosely correlated
+4.98%
JANX - DNLI
56%
Loosely correlated
+2.59%
RCKT - DNLI
56%
Loosely correlated
-0.91%
More

NKTR and

Correlation & Price change

A.I.dvisor indicates that over the last year, NKTR has been loosely correlated with DNLI. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if NKTR jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NKTR
1D Price
Change %
NKTR100%
+8.94%
DNLI - NKTR
43%
Loosely correlated
+0.59%
NTLA - NKTR
43%
Loosely correlated
+2.30%
SLS - NKTR
42%
Loosely correlated
-2.10%
MDGL - NKTR
38%
Loosely correlated
+3.67%
ATAI - NKTR
37%
Loosely correlated
+0.46%
More